Intuitive Surgical, Inc. (NASDAQ:ISRG) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Friday.
Other analysts have also issued research reports about the stock. Canaccord Genuity reiterated a “buy” rating and issued a $870.00 price objective (up previously from $800.00) on shares of Intuitive Surgical in a research note on Wednesday, April 19th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $800.00 to $850.00 and gave the stock a “buy” rating in a research note on Wednesday, April 19th. Goldman Sachs Group, Inc. (The) assumed coverage on shares of Intuitive Surgical in a research note on Tuesday, May 16th. They issued a “buy” rating and a $1,000.00 price objective on the stock. BTIG Research reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Thursday, June 15th. Finally, Citigroup Inc. reiterated a “buy” rating and issued a $917.00 price objective (up previously from $820.00) on shares of Intuitive Surgical in a research note on Saturday, April 22nd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $856.69.
Shares of Intuitive Surgical (NASDAQ ISRG) traded down 0.31% during midday trading on Friday, hitting $951.21. 261,880 shares of the stock were exchanged. The firm’s 50-day moving average is $888.80 and its 200-day moving average is $757.81. The stock has a market cap of $35.04 billion, a price-to-earnings ratio of 47.95 and a beta of 0.41. Intuitive Surgical has a 12 month low of $610.71 and a 12 month high of $954.39.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 18th. The medical equipment provider reported $5.09 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.97 by $1.12. The firm had revenue of $674.20 million for the quarter, compared to analyst estimates of $664.72 million. Intuitive Surgical had a net margin of 27.99% and a return on equity of 15.41%. The business’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.42 earnings per share. Equities research analysts predict that Intuitive Surgical will post $23.64 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://sportsperspectives.com/2017/06/23/intuitive-surgical-inc-isrg-stock-rating-upgraded-by-bidaskclub.html.
In other news, Director Lonnie M. Smith sold 3,000 shares of the firm’s stock in a transaction dated Friday, April 21st. The shares were sold at an average price of $810.12, for a total value of $2,430,360.00. Following the transaction, the director now directly owns 232,638 shares of the company’s stock, valued at $188,464,696.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Alan J. Levy sold 1,386 shares of the firm’s stock in a transaction dated Monday, April 24th. The stock was sold at an average price of $813.15, for a total transaction of $1,127,025.90. Following the completion of the transaction, the director now directly owns 2,598 shares in the company, valued at $2,112,563.70. The disclosure for this sale can be found here. In the last quarter, insiders sold 55,306 shares of company stock worth $46,588,332. Company insiders own 2.50% of the company’s stock.
Several institutional investors have recently bought and sold shares of ISRG. BlackRock Inc. increased its position in Intuitive Surgical by 2,770.9% in the first quarter. BlackRock Inc. now owns 2,846,621 shares of the medical equipment provider’s stock valued at $2,181,851,000 after buying an additional 2,747,465 shares in the last quarter. Vanguard Group Inc. increased its position in Intuitive Surgical by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,503,817 shares of the medical equipment provider’s stock valued at $1,919,101,000 after buying an additional 30,306 shares in the last quarter. FMR LLC increased its position in Intuitive Surgical by 3.4% in the first quarter. FMR LLC now owns 2,277,567 shares of the medical equipment provider’s stock valued at $1,745,686,000 after buying an additional 75,894 shares in the last quarter. Edgewood Management LLC increased its position in Intuitive Surgical by 38.8% in the first quarter. Edgewood Management LLC now owns 919,617 shares of the medical equipment provider’s stock valued at $704,859,000 after buying an additional 257,165 shares in the last quarter. Finally, American Century Companies Inc. increased its position in Intuitive Surgical by 6.0% in the first quarter. American Century Companies Inc. now owns 551,992 shares of the medical equipment provider’s stock valued at $423,085,000 after buying an additional 31,132 shares in the last quarter. 97.56% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.